Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses

Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses

BackgroundCirculating tumour DNA (ctDNA) has been established as a promising (prognostic) biomarker with the potential to personalise treatment in cancer patients. The objective of this systematic review is to provide an overview of the current literature and the future perspectives of ctDNA in non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Jan M. van Rees, Lissa Wullaert, Alexander A. J. Grüter, Yassmina Derraze, Pieter J. Tanis, Henk M. W. Verheul, John W. M. Martens, Saskia M. Wilting, Geraldine Vink, Jeroen L. A. van Vugt, Nick Beije, Cornelis Verhoef
Formato: Artículo
Lenguaje:English
Publicado: Frontiers Media S.A. 2023-01-01
Colección:Frontiers in Oncology
Materias:
Ctdna (circulating tumour DNA)
cfDNA (circulating free DNA)
rectal cancer
minimal residual disease (MRD)
liquid biopsy
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fonc.2023.1083285/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1083285/full

Ejemplares similares